Amikacin pharmacokinetics in elderly patients with severe infections

Medellín‐Garibay, Susanna Edith; Romano‐Aguilar, Melissa; Parada, Alejandro E.; Suarez, David; Romano‐Moreno, Silvia; Barcia, Emilia; Cervero-Jiménez, Miguel; García, Benito

doi:10.1016/j.ejps.2022.106219

Cited by 4 publications

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Aminoglycosides are also among antibiotics whose PK is dramatically affected by renal function decrease. Elimination of amikacin was delayed with increasing age, reflecting glomerular filtration rate decline [ 260 ].…”

Section: General Considerations On Ab Pharmacokinetics In the Elderlymentioning

confidence: 99%

Pharmacokinetics of Antibacterial Agents in the Elderly: The Body of Evidence

et al. 2023

View full text Add to dashboard Cite

Infections are important factors contributing to the morbidity and mortality among elderly patients. High rates of consumption of antimicrobial agents by the elderly may result in increased risk of toxic reactions, deteriorating functions of various organs and systems and leading to the prolongation of hospital stay, admission to the intensive care unit, disability, and lethal outcome. Both safety and efficacy of antibiotics are determined by the values of their plasma concentrations, widely affected by physiologic and pathologic age-related changes specific for the elderly population. Drug absorption, distribution, metabolism, and excretion are altered in different extents depending on functional and morphological changes in the cardiovascular system, gastrointestinal tract, liver, and kidneys. Water and fat content, skeletal muscle mass, nutritional status, use of concomitant drugs are other determinants of pharmacokinetics changes observed in the elderly. The choice of a proper dosing regimen is essential to provide effective and safe antibiotic therapy in terms of attainment of certain pharmacodynamic targets. The objective of this review is to perform a structure of evidence on the age-related changes contributing to the alteration of pharmacokinetic parameters in the elderly.

show abstract

Section: General Considerations On Ab Pharmacokinetics In the Elderlymentioning

confidence: 99%